Comparison ARS Pharmaceuticals (SPRY) with Competitors
ARS Pharmaceuticals (SPRY) industry is Biotechnology.
Profit Margin
SPRY-200.00%
Industry-0.77%
Upside-199.23%
Operating Margin
SPRY-265.20%
Industry-2055.25%
Upside+1790.05%
Debt-to-Equity
SPRY157.44%
Industry28.27%
Upside+456.94%
Free Cash Flow Yield
SPRY-23.38%
Industry-1.75%
Upside-21.64%
P/E
SPRY-3.78
Industry-20.52
Upside+1674.02%
P/S
SPRY7.57
Industry10.01
Upside-24.40%
P/B
SPRY12.33
Industry5.15
Upside+139.57%